Related Experiment Video
Updated: Sep 28, 2026

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
[Fibrinolysis and thrombosis of mechanical valvular prosthesis: risk stratification by transesophageal
R Roudaut1, S Lafitte, M F Roudaut
1Hôpital cardiologique du Haut-Lévêque, CHU de Bordeaux, 33604 Pessac.
Insights
Transesophageal echocardiography aids risk stratification for mechanical heart valve thrombosis. Large, mobile thrombi indicate fibrinolysis is less effective and carries higher risks, suggesting it may be a contraindication.
Area of Science:
- Cardiology
- Medical Imaging
- Interventional Cardiology
Background:
- Fibrinolysis for mechanical heart valve thrombosis remains debated.
- Transesophageal echocardiography (TEE) is crucial for assessing cardiac structures.
Purpose of the Study:
- To define the role of TEE in risk stratification for mechanical heart valve thrombosis.
- To evaluate the effectiveness and safety of fibrinolysis based on TEE findings.
Main Methods:
- A monocentric study of 49 patients with mechanical heart valve thrombosis treated with fibrinolysis.
- TEE was performed prior to thrombolysis to characterize thrombus size, mobility, and obstruction.
- Outcomes (clinical events, fibrinolysis success) were analyzed based on thrombus characteristics.
Main Results:
- Complete fibrinolysis success was 69.4% overall.
- Thrombus size significantly impacted success rates (88% for <10 mm vs. 35% for ≥10 mm, p < 0.01).
- Mobile thrombi were associated with a higher rate of systemic emboli (p < 0.01).
Conclusions:
- TEE is significant in guiding therapeutic choices for valvular prosthesis thrombosis.
- Voluminous and mobile thrombi are contraindications for fibrinolysis due to increased risks and lower success rates.
Abstract:
The place of fibrinolysis in the treatment of mechanical valvular prostheses is still much discussed. The aim of this work is to define the role of transoesophageal echocardiography in risk stratification. This monocentric study draws on 49 cases of thrombolysis preceded by transoesophageal echocardiography (average age 62.1 years, 37 mitral, 11 aortic, 1 tricuspid, 1 mitro-tricuspid). There were 41 obstructive thromboses (OT) and 8 non-obstructive thromboses (NOT). Clinical events and the effectiveness of fibrinolysis were studied as a function of the obstructive or non-obstructive character of the thrombosis and the size of the thrombus < 10 mm (n = 33) or > or = 10 mm (n = 16). Complete success was observed in 34 patients (69.4%). Follow up revealed 2 early cerebral haemorrhages (4.1%) of which one was in the NOT group, and six systemic emboli (12.2%) of which one was in the NOT group. There was a relationship between the size of the thrombus and embolus at the limit of significance in favour of an increased risk of embolus for a voluminous thrombus. Furthermore, the mobility of the thrombi went in hand with an increased rate of systemic emboli (p < 0.01). The rate of failure of fibrinolysis and/or complications correlated with the size of thrombus (complete success in 88% of the < 10 mm thrombus group, versus 35% in the > or = 10 mm; p < 0.01). This work underlines the significance of trans-oesophageal echocardiography in the therapeutic choice for valvular prosthesis thrombosis and suggests that the existence of a voluminous thrombus especially if mobile is a contra-indication for fibrinolysis.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
